跳至主要内容
临床试验/IRCT20190727044343N4
IRCT20190727044343N4已完成3 期

The effectivenees of N-acetylcysteine (NAC) on accelerating renal failer recovery in patient with leptospirosis in Razi Hospital of Ghaemshahr city 2019

Mazandaran University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • People with Glomerular Filteration Rate (GFR) have less than 60 studies.
  • People whose leptospirosis has been confirmed by Enzym-Linked Immunosorbent Assay (ELISA) or Microscopic Agglutination Test (MAT) .
  • Satisfaction to participate in the study.

排除标准

  • Diabetics are excluded from the study.
  • People with underlying liver disease are excluded from the study.
  • People with underlying kidney disease excluded from the study.
  • Patients who have been hospitalized with sepsis symptoms prior to refferal.

研究者

相似试验

The effectiveness of N-acetylcystein (NAC) on... | 临床试验